“Adenosine Monophosphate-Activated Protein Kinase (AMPK) As a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations ”. The Review of Diabetic Studies 6, no. 2 (August 13, 2023). Accessed September 13, 2025. https://diabeticstudies.org/index.php/RDS/article/view/263.